Picture of Syros Pharmaceuticals logo

SYRS Syros Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

U.S. RESEARCH ROUNDUP-Fiverr International, Ncino, Wingstop

Oct 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies, including Fiverr International, Ncino and Wingstop, on Tuesday. 
    
    HIGHLIGHTS
                 * Fiverr International Ltd  FVRR.N : Roth MKM raises to buy from neutral 
 
                 * Ncino Inc  NCNO.O : Stephens cuts to equal-weight from overweight     
 
                 * Warby Parker Inc  WRBY.N : Evercore ISI raises to outperform from in line 
 
                 * Wingstop Inc  WING.O : Jefferies raises to hold from underperform        
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in
alphabetical order. 
 
                 * Academy Sports and Outdoors Inc  ASO.O : TD Cowen cuts target price to $64 from $70 
 
                 * Ally Financial Inc  ALLY.N : Evercore ISI cuts target price to $30 from $32 
 
                 * Cantaloupe Inc  CTLP.O : Berenberg initiates coverage with buy rating; target price $9 
 
                 * Carvana Co  CVNA.N : JP Morgan raises target price to $25 from $20 
 
                 * Caseys General Stores Inc  CASY.O : Jefferies raises target price to $315 from $309 
 
                 * Cava Group Inc  CAVA.N : Jefferies cuts target price to $48 from $54 
 
                 * CBRE Group Inc  CBRE.N : KBW cuts target price to $85 from $93 
 
                 * Chuy's Holdings Inc  CHUY.O : Jefferies cuts target price to $45 from $47 
 
                 * Columbia Sportswear Co  COLM.O : TD Cowen cuts target price to $74 from $83 
 
                 * Dutch Bros Inc  BROS.N : Jefferies cuts target price to $35 from $41 
 
                 * Fiverr International Ltd  FVRR.N : Roth MKM raises to buy from neutral 
 
                 * Jack In the Box Inc  JACK.O : Jefferies cuts target price to $76 from $95 
 
                 * Kinetik Holdings Inc  KNTK.N : JP Morgan raises target price to $39 from $38 
 
                 * McDonald's  MCD.N : Jefferies cuts target price to $325 from $340 
 
                 * Mirum Pharmaceuticals Inc  MIRM.O : Baird raises target price to $38 from $35 
 
                 * Murphy USA Inc  MUSA.N : Jefferies raises target price to $355 from $314 
 
                 * Ncino Inc  NCNO.O : Stephens cuts to equal-weight from overweight 
 
                 * Nextera Energy Partners LP  NEP.N : CIBC cuts target price to $32 from $62 
 
                 * Pepsico Inc  PEP.O : Evercore ISI cuts target price to $185 from $195 
 
                 * Pepsico Inc  PEP.O : JP Morgan cuts target price to $188 from $203 
 
                 * Portillos Inc  PTLO.O : Jefferies cuts target price to $25 from $30 
 
                 * PVH Corp  PVH.N : TD Cowen cuts target price to $86 from $95 
 
                 * Red Robin Gourmet Burgers Inc  RRGB.O : Jefferies cuts target price to $9 from $12 
 
                 * Starbucks Corp  SBUX.O : Jefferies cuts target price to $100 from $107 
 
                 * Syros Pharmaceuticals Inc  SYRS.O : Piper Sandler cuts target price to $7 from $11 
 
                 * Topgolf Callaway Brands Corp  MODG.N : TD Cowen cuts target price to $14 from $16 
 
                 * Travere Therapeutics Inc  TVTX.O : Canaccord Genuity cuts target price to $15 from $35 
 
                 * under Armour Inc  UAA.N : TD Cowen cuts target price to $6 from $7 
 
                 * Valero Energy Corp  VLO.N : Piper Sandler raises target price to $171 from $168 
 
                 * VF Corp  VFC.N : TD Cowen cuts target price to $19 from $23 
 
                 * Warby Parker Inc  WRBY.N : Evercore ISI raises to outperform from in line 
 
                 * Wingstop Inc  WING.O : Jefferies raises to hold from underperform
 
                 * Wingstop Inc  WING.O : Jefferies raises target price to $170 from $150 
 
       

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Syros Pharmaceuticals

See all news